C12N 2501/15
Transforming growth factor beta
Official title: Transforming growth factor beta (TGF-β)
C12N2501/15 (Transforming growth factor beta) appears on 826 US grants and 1,866 published applications in this corpus.
Search patents in C12N- Granted patents
- 826
- Published applications
- 1,866
- Assignees
- 751
- Inventors
- 3,257
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 9 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 1 |
| 2002 | 7 | 12 |
| 2003 | 6 | 30 |
| 2004 | 10 | 21 |
| 2005 | 5 | 23 |
| 2006 | 9 | 26 |
| 2007 | 6 | 20 |
| 2008 | 10 | 26 |
| 2009 | 8 | 36 |
| 2010 | 18 | 45 |
| 2011 | 7 | 40 |
| 2012 | 20 | 45 |
| 2013 | 17 | 52 |
| 2014 | 28 | 57 |
| 2015 | 33 | 62 |
| 2016 | 38 | 76 |
| 2017 | 49 | 81 |
| 2018 | 49 | 89 |
| 2019 | 59 | 116 |
| 2020 | 49 | 115 |
| 2021 | 51 | 133 |
| 2022 | 51 | 153 |
| 2023 | 52 | 157 |
| 2024 | 77 | 180 |
| 2025 | 77 | 164 |
| 2026 | 56 | 106 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ex vivo proliferation of epithelial cells29 Sep 2026US 12,747,425 B2Propagenix Inc.
- Methods of differentiating neural cells and related compositions and methods of use15 Sep 2026US 12,734,196 B2Aspen Neuroscience, Inc.
- Generation of uniform hepatocytes from human embryonic stem cells by inhibiting TGF-beta and methods of maintaining hepatic cultures15 Sep 2026US 12,734,197 B2Wisconsin Alumni Research Foundation
- Functional cortical organoids, methods of making, and uses thereof15 Sep 2026US 12,736,527 B2The Regents of the University of California
- Method of in vitro chondrocyte and cartilage culture to obtain material for the treatment of articular cartilage defects25 Aug 2026US 12,714,766 B2Arthec S.A.
- Methods and compositions related to platelet releasate and platelet-rich fibrin8 Oct 2026US 2026/0306546 A1Biobridge Global
- Application of stem cells or transgenic stem cells8 Oct 2026US 2026/0306716 A1Anhui Longhui Stem Cell Biotechnology Co., Ltd
- Micropattern-assisted generation of tissue8 Oct 2026US 2026/0308533 A1
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Oct3/4 protein variants, and method for producing induced pluripotent stem cells1 Oct 2026US 2026/0297535 A1Riken
Most cited
By later US patents
- Osteoarthritis cartilage regeneration361US 6,835,377 B2Osiris Therapeutics, Inc. · 2004
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- Three-dimensional cartilage cultures289US 5,902,741 AAdvanced Tissue Sciences, Inc. · 1999
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Definitive endoderm221US 7,510,876 B2Cythera, Inc. · 2009